Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian T Ruff

Showing results (1-10 of 192) with videos related to

Pageof 20
Sort By:
The Journal of Innovations in Cardiac Rhythm Management|June 2, 2020
Reversal Agents: What We Have and What We Can ExpectChristian T Ruff
Journal of the American College of Cardiology|August 14, 2015
The Challenge of Getting it Just Right: Optimizing Long-Term Antithrombotic Therapy After Acute Coronary SyndromeChristian T Ruff
Journal of the American College of Cardiology|September 24, 2016
The Reality of "Real-World" Data: More Questions Than AnswersChristian T Ruff
Clinical Chemistry|June 27, 2018
Pharmacogenetics of Warfarin TherapyChristian T Ruff
Journal of the American College of Cardiology|April 4, 2020
The Promise of Mobile Health in Managing Atrial FibrillationChristian T Ruff
Circulation|April 25, 2012
Cardiology patient page: stroke prevention in atrial fibrillationChristian T Ruff
American Heart Journal Plus : Cardiology Research and Practice|April 1, 2024
The importance of dosing frequency on the safety of DOACsChristian T Ruff
Nature Reviews. Cardiology|December 22, 2010
The evolving epidemiology of acute coronary syndromesChristian T Ruff, Eugene Braunwald
Journal of Cardiovascular Pharmacology and Therapeutics|May 21, 2010
Will warfarin ever be replaced?Christian T Ruff, Eugene Braunwald
Therapeutic Advances in Cardiovascular Disease|December 19, 2015
Edoxaban in patients with atrial fibrillationAlon Eisen, Christian T Ruff
Pageof 20

Showing results (1-10 of 192) with videos related to

Sort By:
Pageof 20
The Journal of Innovations in Cardiac Rhythm Management|June 2, 2020
Reversal Agents: What We Have and What We Can ExpectChristian T Ruff
Journal of the American College of Cardiology|August 14, 2015
The Challenge of Getting it Just Right: Optimizing Long-Term Antithrombotic Therapy After Acute Coronary SyndromeChristian T Ruff
Journal of the American College of Cardiology|September 24, 2016
The Reality of "Real-World" Data: More Questions Than AnswersChristian T Ruff
Clinical Chemistry|June 27, 2018
Pharmacogenetics of Warfarin TherapyChristian T Ruff
Journal of the American College of Cardiology|April 4, 2020
The Promise of Mobile Health in Managing Atrial FibrillationChristian T Ruff
Circulation|April 25, 2012
Cardiology patient page: stroke prevention in atrial fibrillationChristian T Ruff
American Heart Journal Plus : Cardiology Research and Practice|April 1, 2024
The importance of dosing frequency on the safety of DOACsChristian T Ruff
Nature Reviews. Cardiology|December 22, 2010
The evolving epidemiology of acute coronary syndromesChristian T Ruff, Eugene Braunwald
Journal of Cardiovascular Pharmacology and Therapeutics|May 21, 2010
Will warfarin ever be replaced?Christian T Ruff, Eugene Braunwald
Therapeutic Advances in Cardiovascular Disease|December 19, 2015
Edoxaban in patients with atrial fibrillationAlon Eisen, Christian T Ruff
Pageof 20